Enhanced SARS-CoV-2 breakthrough infections in patients with hematologic and solid cancers due to Omicron.

Maximilian J Mair; Manfred Mitterer; Pia Gattinger; Julia M Berger; Wolfgang Trutschnig; Arne C Bathke; Margaretha Gansterer; Anna S Berghoff; Severin Laengle; Lynn Gottmann; Thomas Buratti; Helmuth Haslacher; Wolfgang W Lamm; Markus Raderer; Selma Tobudic; Thorsten Fuereder; Rudolf Valenta; Dominic Fong; Matthias Preusser

doi:10.1016/j.ccell.2022.04.003

Enhanced SARS-CoV-2 breakthrough infections in patients with hematologic and solid cancers due to Omicron.

Maximilian J Mair, Manfred Mitterer, Pia Gattinger, Julia M Berger, Wolfgang Trutschnig, Arne C Bathke, Margaretha Gansterer, Anna S Berghoff, Severin Laengle, Lynn Gottmann, Thomas Buratti, Helmuth Haslacher, Wolfgang W Lamm, Markus Raderer, Selma Tobudic, Thorsten Fuereder, Rudolf Valenta, Dominic Fong, Matthias Preusser

Krankenhaus Meran

Publikation: Beitrag in Fachzeitschrift › Letter to the editor › Begutachtung

26 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	444-446
Fachzeitschrift	CANCER CELL
Jahrgang	40
Ausgabenummer	5
DOIs	https://doi.org/10.1016/j.ccell.2022.04.003
Publikationsstatus	Veröffentlicht - 2022

Zugriff auf Dokument

10.1016/j.ccell.2022.04.003

Dieses zitieren

Mair, M. J., Mitterer, M., Gattinger, P., Berger, J. M., Trutschnig, W., Bathke, A. C., Gansterer, M., Berghoff, A. S., Laengle, S., Gottmann, L., Buratti, T., Haslacher, H., Lamm, W. W., Raderer, M., Tobudic, S., Fuereder, T., Valenta, R., Fong, D., & Preusser, M. (2022). Enhanced SARS-CoV-2 breakthrough infections in patients with hematologic and solid cancers due to Omicron. CANCER CELL, 40(5), 444-446. https://doi.org/10.1016/j.ccell.2022.04.003

@article{8a010ce0808146e09e4e3e113b63a5a5,

title = "Enhanced SARS-CoV-2 breakthrough infections in patients with hematologic and solid cancers due to Omicron.",

author = "Mair, {Maximilian J} and Manfred Mitterer and Pia Gattinger and Berger, {Julia M} and Wolfgang Trutschnig and Bathke, {Arne C} and Margaretha Gansterer and Berghoff, {Anna S} and Severin Laengle and Lynn Gottmann and Thomas Buratti and Helmuth Haslacher and Lamm, {Wolfgang W} and Markus Raderer and Selma Tobudic and Thorsten Fuereder and Rudolf Valenta and Dominic Fong and Matthias Preusser",

note = "Lehr-KH Meran: Franz Tappeiner Hospital, Meran/Merano, Italy",

year = "2022",

doi = "10.1016/j.ccell.2022.04.003",

language = "English",

volume = "40",

pages = "444--446",

journal = "CANCER CELL",

issn = "1535-6108",

publisher = "Cell Press ",

number = "5",

}

Mair, MJ, Mitterer, M, Gattinger, P, Berger, JM, Trutschnig, W, Bathke, AC, Gansterer, M, Berghoff, AS, Laengle, S, Gottmann, L, Buratti, T, Haslacher, H, Lamm, WW, Raderer, M, Tobudic, S, Fuereder, T, Valenta, R, Fong, D & Preusser, M 2022, 'Enhanced SARS-CoV-2 breakthrough infections in patients with hematologic and solid cancers due to Omicron.', CANCER CELL, Jg. 40, Nr. 5, S. 444-446. https://doi.org/10.1016/j.ccell.2022.04.003

TY - JOUR

T1 - Enhanced SARS-CoV-2 breakthrough infections in patients with hematologic and solid cancers due to Omicron.

AU - Mair, Maximilian J

AU - Mitterer, Manfred

AU - Gattinger, Pia

AU - Berger, Julia M

AU - Trutschnig, Wolfgang

AU - Bathke, Arne C

AU - Gansterer, Margaretha

AU - Berghoff, Anna S

AU - Laengle, Severin

AU - Gottmann, Lynn

AU - Buratti, Thomas

AU - Haslacher, Helmuth

AU - Lamm, Wolfgang W

AU - Raderer, Markus

AU - Tobudic, Selma

AU - Fuereder, Thorsten

AU - Valenta, Rudolf

AU - Fong, Dominic

AU - Preusser, Matthias

N1 - Lehr-KH Meran: Franz Tappeiner Hospital, Meran/Merano, Italy

PY - 2022

Y1 - 2022

U2 - 10.1016/j.ccell.2022.04.003

DO - 10.1016/j.ccell.2022.04.003

M3 - Letter to the editor

C2 - 35429443

SN - 1535-6108

VL - 40

SP - 444

EP - 446

JO - CANCER CELL

JF - CANCER CELL

IS - 5

ER -